Viewing Study NCT04580420


Ignite Creation Date: 2025-12-25 @ 4:18 AM
Ignite Modification Date: 2025-12-26 @ 3:18 AM
Study NCT ID: NCT04580420
Status: RECRUITING
Last Update Posted: 2025-12-24
First Post: 2020-09-24
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Safety & Efficacy of DCR-PHXC in Patients With PH1 and ESRD
Sponsor: Dicerna Pharmaceuticals, Inc., a Novo Nordisk company
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module